Cubist Systematic Strategies LLC Increases Position in Boston Scientific Corp (BSX)

May 18, 2018 - By John Moody

Boston Scientific Corporation (NYSE:BSX) LogoInvestors sentiment increased to 1.34 in Q4 2017. Its up 0.30, from 1.04 in 2017Q3. It is positive, as 36 investors sold BSX shares while 158 reduced holdings. 86 funds opened positions while 174 raised stakes. 1.18 billion shares or 2.38% less from 1.21 billion shares in 2017Q3 were reported. Essex Mgmt Com Ltd Company has 17,352 shares for 0.06% of their portfolio. Aperio Gp Lc holds 0.07% or 519,407 shares. Fund Mgmt Sa reported 0.07% in Boston Scientific Corporation (NYSE:BSX). Whittier Tru Co holds 0% or 813 shares in its portfolio. Nelson Roberts Investment Advisors Limited Com owns 73 shares. Global X Mngmt Limited Liability Co reported 0.02% stake. Tower Rech Cap Limited Liability (Trc) accumulated 0.08% or 25,677 shares. North Star Inv Mgmt holds 0% of its portfolio in Boston Scientific Corporation (NYSE:BSX) for 1,080 shares. 3.80M are owned by Morgan Stanley. Bp Public Lc invested 0.14% of its portfolio in Boston Scientific Corporation (NYSE:BSX). 97,749 were accumulated by M&T Bank Corp. Arizona State Retirement Systems holds 0.11% in Boston Scientific Corporation (NYSE:BSX) or 464,781 shares. Caxton Assoc Limited Partnership stated it has 44,975 shares or 0.05% of all its holdings. Great West Life Assurance Co Can stated it has 0.06% of its portfolio in Boston Scientific Corporation (NYSE:BSX). Magnetar Fincl Lc owns 151,613 shares.

Since December 29, 2017, it had 0 insider purchases, and 17 insider sales for $8.68 million activity. On Friday, December 29 the insider Phalen Michael P. sold $399,865. 14,150 shares valued at $381,949 were sold by Sorenson John Bradley on Thursday, March 1. Butcher Arthur C sold $225,413 worth of stock. Ballinger Kevin J. also sold $931,680 worth of Boston Scientific Corporation (NYSE:BSX) on Monday, May 7. Another trade for 60,209 shares valued at $1.68 million was made by Brennan Daniel J. on Monday, March 19. 85,227 shares valued at $2.26M were sold by Fitzgerald Joseph Michael on Wednesday, February 7.

Cubist Systematic Strategies Llc increased its stake in Boston Scientific Corp (BSX) by 3712.35% based on its latest 2017Q4 regulatory filing with the SEC. Cubist Systematic Strategies Llc bought 493,483 shares as the company’s stock rose 7.69% while stock markets declined. The institutional investor held 506,776 shares of the medical and dental instruments company at the end of 2017Q4, valued at $12.56 million, up from 13,293 at the end of the previous reported quarter. Cubist Systematic Strategies Llc who had been investing in Boston Scientific Corp for a number of months, seems to be bullish on the $41.83B market cap company. The stock increased 1.17% or $0.35 during the last trading session, reaching $30.32. About 7.30 million shares traded or 2.64% up from the average. Boston Scientific Corporation (NYSE:BSX) has risen 9.97% since May 18, 2017 and is uptrending. It has underperformed by 1.58% the S&P500.

Cubist Systematic Strategies Llc, which manages about $1.88B US Long portfolio, decreased its stake in Nvidia Corp (NASDAQ:NVDA) by 63,754 shares to 8,652 shares, valued at $1.67 million in 2017Q4, according to the filing. It also reduced its holding in Air Prods & Chems Inc (NYSE:APD) by 23,317 shares in the quarter, leaving it with 4,330 shares, and cut its stake in Mastercard Incorporated (NYSE:MA).

More important recent Boston Scientific Corporation (NYSE:BSX) news were published by: Seekingalpha.com which released: “Highlights from Appaloosa’s Q1” on May 15, 2018, also Forbes.com published article titled: “A Quick Snapshot Of Boston Scientific’s Rhythm Management & Neuro Segment”, Streetinsider.com published: “JANA Shows New Stakes in Apple (AAPL), Boston Scientific (BSX), Dropbox (DBX), iQIYI (IQ) (more..) -13F” on May 15, 2018. More interesting news about Boston Scientific Corporation (NYSE:BSX) was released by: Streetinsider.com and their article: “Pre-Open Movers 05/14: (ACIA) (SHLD) (NXPI) Higher; (XRX) (DF) (BSX) Lower (more…)” with publication date: May 14, 2018.

Boston Scientific Corporation (NYSE:BSX) Ratings Coverage

Among 18 analysts covering Boston Scientific Corp (NYSE:BSX), 16 have Buy rating, 0 Sell and 2 Hold. Therefore 89% are positive. Boston Scientific Corp had 29 analyst reports since November 28, 2017 according to SRatingsIntel. The stock of Boston Scientific Corporation (NYSE:BSX) has “Buy” rating given on Wednesday, November 29 by BMO Capital Markets. As per Thursday, April 5, the company rating was maintained by Bank of America. The stock has “Hold” rating by Jefferies on Friday, February 2. The rating was maintained by Cowen & Co on Wednesday, November 29 with “Buy”. The rating was maintained by Canaccord Genuity with “Buy” on Wednesday, November 29. The firm earned “Buy” rating on Friday, December 8 by Needham. The firm earned “Hold” rating on Wednesday, April 25 by Jefferies. The firm earned “Overweight” rating on Thursday, April 26 by JP Morgan. As per Tuesday, May 1, the company rating was maintained by Citigroup. The stock of Boston Scientific Corporation (NYSE:BSX) earned “Buy” rating by Piper Jaffray on Friday, February 23.

Boston Scientific Corporation (NYSE:BSX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: